| Satellos has a very simple but powerful discovery--a way to regenerate muscle, and its first testing is for Duchennes Muscular Dystrophy. Efficacy results will come forward in Q2 25, giving the stock a huge potential catalyst. Satellos doesn't just aim to slow muscle degeneration, but increase, regenerate, muscle tissue. This could be a big winner! Canine data from 2024 was both powerful and quick to show results.
Sign up below to get your full copy of our report, for free. |
